Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms, Glandular and Epithelial × lenvatinib × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 15 Cholangiocarcinoma 3 Thyroid Neoplasms 2 Recurrence 1 Neoplasms, Glandular and Epithelial 1 Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Coitus 1 Carcinoma, Renal Cell 1 Carcinoma 1 Biliary Tract Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04008082 2022-03-08

A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma

Eisai Inc.

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Neoplasms, Neoplasms, Glandular and Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡